|
|
|
|
Fibromyalgia
|
|
Fibromyalgia treatments with up to 77% symptom relief.
|
|
|
Rheumatoid Arthritis (RA)
|
|
Rheumatoid Arthritis treatments with up to 80% symptom relief.
|
|
|
Osteoarthritis (OA)
|
|
Osteoarthritis Arthritis treatments with up to 78% symptom relief.
|
|
|
Arthritis (Undiagnosed)
|
|
Find Relief from any form of Arthritis with an average of 75% symptom relief.
|
|
|
|
|
A Simple Solution: Book and DVD
If you wish to read more about Virgil and Helen, and the creation of Microdose Therapy, pick up Virgil's book
Out of Order
Click on the images above to learn more about this offer.
|
|

|
|
Articles on the basics of Microdose Therapy
Read about Microdose Therapy and its effect on Fibromyalgia, Arthritis, Rheumatoid Arthritis, Osteo Arthritis and Ploymyalgia Rheumatica. Learn about the alternative solution to pain, fatigure and inflammation through a natural healing treatment.
Inflammation Control System Discovery: Stenberg VI, Bouley MG, Katz BM, Lee KJ, Parmar SS. Negative endocrine control system for inflammation in rats. Agents and Actions, 29: 189-195, 1990.
Clinical Trial on the Solution: Stenberg VI, Fiechtner JJ, Rice JR, Miller DR, Johnson LK. Endocrine control of inflammation: rheumatoid arthritis double-blind, crossover clinical trial. Int J Clin Pharm Res , 12(1): 11-18, 1992.
Feature articles on Microdose Therapy
Glucocorticoids Rehabiliated: Low Cost, Effectiveness, Patient Compliance Cited, Rheumatology News, 1991, 18, 3.
Reintroducing Steroids: ‘Near-Perfect’ Therapy Controlled by the Patient? Current Rheumatology, 1991, 12(4), 7.
Hormone Offers Hope for Victims of Inflammation, Hospital Doctor, 1991, C11(9), 11-18.
Pain, Pain, Go Away, by Tom R. Kovach, OMNI.
Lectures on Microdose Therapy
Stenberg VI. The hypothalamus/pituitary glands and the etiology of rheumatoid arthritis. Recent Advances in Mediators of Inflammation and Anti-inflammatory Agents, Regional Research Laboratory, Jammu-Tawi, India, November 3, 1984.
Stenberg, VI. The hypothalamus/pituitary glands and the etiology of rheumatoid arthritis. Central Drug Research Institute, Lucknow, India, November 6, 1984.
Stenberg, VI. The Etiology and Therapy of Rheumatoid Arthritis, University of Oslo, Institute of Immunology and Rheumatology, Rikshophitalet, Oslo, Norway, July 1, 1985.
Stenberg, VI. The Etiology and Therapy of Rheumatoid Arthritis, Riker Laboratories, Inc., 3M Company, St. Paul, MN, February 28, 1986.
Stenberg, VI. On the Etiology and Therapy of Rheumatoid Arthritis, E.I. Dupont Company, Experimental Station, Wilmington, DE, May 28, 1986.
Stenberg, VI. On the Theory and Therapy of Rheumatoid Arthritis, University of Florida Medical School, Gainesville, FL, January 16, 1987.
Fiechtner, J.J., Miller, D. and Stenberg, V.I., Control of Rheumatoid Arthritis and Low Dose P.R.N. Prednisone, 2nd Congress of the International Society for Rheumatic Therapy, London, U.K., June 25-29, 1990.
Fiechtner, J.J., Miller, D. and Stenberg, V.I., Control of Rheumatoid Arthritis and Low Dose P.R.N. Prednisone: A Patient Initiated Flare Response Regimen, 155th meeting of the American College of Rheumatology, Boston, MA, November 17-21, 1991.
Stenberg VI, Fiechtner JJ, Johnson LK, Miller DT. Rheumatoid arthritis: patient diary design and validation. Interscience World Conference on Inflammation, Geneva, Switzerland, 1993.
|
|